Table 1 Baseline characteristics before (Group 1) and after the implementation of the Life-Sustaining Treatment Decisions Act (Group 2)
Characteristics | Group 1 (n = 943) | Group 2 (n = 891) | p-value | |
|---|---|---|---|---|
No. (%) | No. (%) | |||
Age at death (Mean ± SD) | 64.9 ± 10.9 | 66.1 ± 11.1 | 0.906 | |
Sex, male | 634 (67.2 %) | 564 (63.3 %) | 0.078 | |
Primary site of cancer | Head and neck cancer | 31 (3.3 %) | 18 (2.0 %) | 0.124 |
Esophageal cancer | 27 (2.9 %) | 15 (1.7 %) | ||
Lung cancer | 254 (26.98 %) | 260 (29.2 %) | ||
Breast cancer | 48 (5.1 %) | 56 (6.3 %) | ||
Stomach cancer | 106 (11.2 %) | 90 (10.1 %) | ||
Colorectal cancer | 95 (10.1 %) | 94 (10.5 %) | ||
Hepatobiliary cancer | 292 (31.0 %) | 253 (28.4 %) | ||
Pancreatic cancer | 90 (9.5 %) | 105 (11.8 %) | ||
Education | ≤ 12 years | 816 (86.5 %) | 781 (87.7 %) | 0.935 |
> 12 years | 122 (12.9 %) | 94 (10.5 %) | ||
Healthcare insurance | NHI | 880 (93.3 %) | 853 (95.7 %) | 0.018 |
Medical aid | 63 (6.7 %) | 37 (4.2 %) | ||
Received chemotherapy | 475 (50.4 %) | 486 (54.5 %) | 0.076 | |